Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the BreathID Methacetin Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients Awaiting Liver Transplantation

NCT01157845 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01157845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01157845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the BreathID Methacetin Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients Awaiting Liver Transplantation
Lead sponsor
Virginia Commonwealth University
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2012
Enrollment
165 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis